ArticleCancer biomarkers : section A of Disease markers2022

Mass spectrometry, data re-analysis, and homology modelling predict posttranslational modifications of leucine-rich alpha-2-glycoprotein as a marker of myelodysplastic syndrome.

Pavel Majek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.